Researchers also are working on ultra-extensive-performing GLP-one analogs that could need dosing just once per month or perhaps significantly less frequently. These prolonged-release versions could allow it to be even much easier to stay with having GLP-1s.  Semaglutide imitates the actions of GLP one by stimulating insulin output through the pa